Severe 5-Fluorouracil Toxicity Possibly Secondary to Dihydropyrimidine Dehydrogenase Deficiency in a Breast Cancer Patient with Osteogenesis Imperfecta

By Beuzeboc P.   Pierga J.-Y.   Stoppa-Lyonnet D.   Etienne M.C.   Milano G.   Pouillart P.  

European Journal of Cancer, Vol. 32, Iss. 2, 1996-02 ,pp. : 369-370

Elsevier

Access to resources Recommend Favorite

Association and prediction of severe 5-fluorouracil toxicity with dihydropyrimidine dehydrogenase gene polymorphisms: A meta-analysis

By    

Biomedical Reports, Vol. 3, Iss. 6, 2015-01 ,pp. : 879-883

Science Publishers

Access to resources Recommend Favorite

Thymidylate Synthase and Dihydropyrimidine Dehydrogenase are Related to Histological Effects of 5-Fluorouracil and Cisplatin Neoadjuvant Chemotherapy for Primary Gastric Cancer Patients

By Fukuda Hiroyuki   Takiguchi Nobuhiro   Koda Kenji   Oda Kenji   Seike Kazuhiro   Miyazaki Masaru  

Cancer Investigation, Vol. 24, Iss. 3, 2006-05 ,pp. : 235-241

Informa Healthcare

Access to resources Recommend Favorite

Can dihydropyrimidine dehydrogenase impact 5-fluorouracil-based treatment? - results of a phase I/II trial

By Milano G.   McLeod H.L.  

European Journal of Cancer, Vol. 36, Iss. 1, 2000-01 ,pp. : 37-42

Elsevier

Access to resources Recommend Favorite

Dihydropyrimidine dehydrogenase and fluoropyrimidines: a review of current dose adaptation practices and the impact on the future of personalized medicine using 5-fluorouracil

By Boisdron-Celle Michèle   Biason Paola   Gamelin Erick   Morel Alain  

Colorectal Cancer, Vol. 2, Iss. 6, 2013-12 ,pp. : 549-558

Future Medicine

Access to resources Recommend Favorite